Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
# Head BD&L Transactions ImmunologyREQ- Jul 01, 2026SwitzerlandAvailable in:English# Summary#LI-Hybrid Location: Basel, Switzerland What if the deals you shape today could define the future of healthcare? As Head BD&L Transactions, Immunology, you’ll be at the heart
Company Description Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come
Join us on our exciting journey! IQVIA is The Human Data Science Company, focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health